Brain and Nervous System Clinical Trial
Official title:
Phase I Clinical Trial of Locoregionally (LR) Delivered Autologous B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Adults With Recurrent Glioblastoma Multiforme (GBM)
This is an open label, non-randomized, single site Phase I study to test the manufacturing feasibility and safety of locoregional (LR) administration of B7-H3CART into the central nervous system of adult subjects with recurrent IDH wild-type GBM using a standard 3+3 dose escalation design.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01778764 -
Phase I Compare OS in Post-CyberKnife Radiosurgery Tx in 1-3 VS 4 or More Brain Metastases
|
||
| Active, not recruiting |
NCT04022980 -
Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma
|
Phase 1 | |
| Completed |
NCT00251797 -
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors
|
Phase 1 | |
| Withdrawn |
NCT04770831 -
Patients Who Receive 131 I-MIBG
|
||
| Completed |
NCT03076255 -
Head and Neck Maskless Immobilization Device in Immobilizing Patients With Head and Neck Cancer or Intracranial Tumors Undergoing Radiation Therapy
|
N/A |